PATENT CLAIM ANALYSIS

Application Number: 16252418
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["530", "388100"]

Abstract:
Provided are anti-PD-1 antibodies or fragments thereof. In various example, the antibodies or fragments thereof includes a heavy chain variable region comprising heavy chain complementarity determining regions HCDR1, HCDR2, and HCDR3, and a light chain variable region comprising light chain complementarity determining regions LCDR1, LCDR2, and LCDR3. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer, infection or immune disorders are also provided.

Claim (Index 5):
The antibody or fragment thereof of  claim 4 , wherein the isotype is IgG1, IgG2, IgG3 or IgG4.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.73913
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14603808', '15858963', '14603776', '15289032', '16159506']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7646994714639643
- 35 USC 102 Novelty (BERT): 0.5814070539635289
- Combined Prediction Score: 0.7463702297139208
- Mean Citation Score: 477.7584800000001
- Max Citation Score: 502.97955
- Similarity Product: 410.2884807986141

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test